On this week’s Tech Nation, Moira speaks with ROBERT SIEGEL, Venture Investor and Stanford University Lecturer, and the Author of “The Brains and Brawn Company … How Leading Organizations blend the best of Digital and Physical.” Then, intervening with “cytokine storms”. JIM JOYCE, the CEO of San Diego’s Sigyn Therapeutics talks about their progress to […]

Athersys was started about 25 years ago and is currently developing MultiStem®, a proprietary stem cell product for the treatment of diseases and conditions in the neurological, inflammatory, and immune areas. The company has a clinical trial underway in each of those areas and is conducting studies in the U.S. and internationally. “Our MultiStem product […]

DocWire News recently talked to Spiro Rombotis, CEO of Cyclacel Pharmaceuticals, Inc., a company developing innovative therapies that target various phases of cell control for treating advanced cancers, among other serious diseases. Mr. Rombotis discussed the strides his company is making in developing and testing targeted therapies that may actually drive cancer cells “to commit suicide.” […]